exo-N-[5-({3-[5-(Acetyl-hydroxy-amino)-pentylcarbamoyl]-propionyl}-hydroxy-amino)-pentyl]-N'-hydroxy-N'-{5-[(4-pentyl-bicyclo[2.2.2]octane-2-carbonyl)-amino]-pentyl}-succinamide

ID: ALA4210574

Chembl Id: CHEMBL4210574

PubChem CID: 145964760

Max Phase: Preclinical

Molecular Formula: C39H70N6O9

Molecular Weight: 767.02

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCC[C@]12CC[C@@H](CC1)[C@@H](C(=O)NCCCCCN(O)C(=O)CCC(=O)NCCCCCN(O)C(=O)CCC(=O)NCCCCCN(O)C(C)=O)C2

Standard InChI:  InChI=1S/C39H70N6O9/c1-3-4-8-21-39-22-19-32(20-23-39)33(30-39)38(51)42-26-11-7-14-29-45(54)37(50)18-16-35(48)41-25-10-6-13-28-44(53)36(49)17-15-34(47)40-24-9-5-12-27-43(52)31(2)46/h32-33,52-54H,3-30H2,1-2H3,(H,40,47)(H,41,48)(H,42,51)/t32-,33-,39-/m0/s1

Standard InChI Key:  SULMNBXGAWUGSR-SVWFWBBMSA-N

Alternative Forms

  1. Parent:

    ALA4210574

    ---

Associated Targets(Human)

SK-N-BE(2)-M17 (195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Astrocyte (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 767.02Molecular Weight (Monoisotopic): 766.5204AlogP: 4.86#Rotatable Bonds: 29
Polar Surface Area: 208.92Molecular Species: NEUTRALHBA: 9HBD: 6
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.92CX Basic pKa: CX LogP: 2.10CX LogD: 1.98
Aromatic Rings: Heavy Atoms: 54QED Weighted: 0.03Np Likeness Score: 0.23

References

1. Telfer TJ, Liddell JR, Duncan C, White AR, Codd R..  (2017)  Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease.,  27  (8): [PMID:28285915] [10.1016/j.bmcl.2017.03.001]

Source